2020

研究業績

Papers (English)

Original papers

1. Adachi Y, Yoshikawa H, Yokoyama S, Iwasa K. Characteristics of university students supported by counseling services: Analysis of psychological tests and pulse rate variability. PLoS One 15:e0218357, 2020

2. Fujiwara T, Ono M, Iizuka T, Sekizuka-Kagami N, Maida Y, Adachi Y, Fujiwara H, Yoshikawa H. Breakfast skipping in female college students is a potential and preventable predictor of gynecologic disorders at health service centers. Diagnostics (Basel) 10:476, 2020

3. Fujiwara T, Ono M, Mieda M, Yoshikawa H, Nakata R, Daikoku T, Sekizuka-Kagami N, Maida Y, Ando H, Fujiwara H. Adolescent dietary habit-induced obstetric and gynecologic disease (ADHOGD) as a new hypothesis-possible involvement of clock system. Nutrients 12:1294, 2020

4. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Arai K, Koide M, Katada F, Harada M, Murai H, Murayama S, Tsukamoto T, Mizusawa H, Yamada M. Characterization of sporadic Creutzfeldt-Jakob disease and history of neurosurgery to identify potentially iatrogenic cases. Emerg Infect Dis 26:1140-1146, 2020

5. Hamaguchi T, Sanjo N, Ae R, Nakamura Y, Sakai K, Takao M, Murayama S, Iwasaki Y, Satoh K, Murai H, Harada M, Tsukamoto T, Mizusawa H, Yamada M. MM2 type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg Psychiatry 91:1158-1165, 2020

6. Hayashida S, Masaki K, Suzuki OS, Yamasaki R, Watanabe M, Koyama S, Isobe N, Matsushita T, Takahashi K, Tabira T, Iwaki T, Kira J. Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló’s disease and neuromyelitis optica spectrum disorders. Brain Pathol 30:1144-1157, 2020

7. Ikeda Y, Kikuchi M, Noguchi-Shinohara M, Iwasa K, Kameya M, Hirosawa T, Yoshita M, Ono K, Samuraki-Yokohama M, Yamada M. Spontaneous MEG activity of the cerebral cortex during eyes closed and open discriminates Alzheimer’s disease from cognitively normal older adults. Sci Rep 10:9132, 2020

8. Ishida N, Kondo Y, Chikano Y, Kobayashi-Nakade E, Suga Y, Ishizaki J, Komai K, Matsushita R. Pharmacokinetics and tissue distribution of 3,4-diaminopyridine in rats. Biopharm Drug Dispos 40:294-301, 2019 (2019年報掲載漏れ)

9. Ishida C, Kato-Motozaki Y, Noto D, Komai K, Hasegawa M, Ikeuchi T, Yamada M. An autopsy case of corticobasal degeneration with the inferior olivary hypertrophy. Neuropathology (In Press)

10. Ishida C, Takahashi K, Kato-Motozaki Y, Tagami A, Komai K. Effectiveness of levodopa in patients with multiple system atrophy and associated clinicopathological features. Intern Med (In Press)

11. Kashihara T, Nozaki I, Sakai K, Minamikawa J, Nakamura-Shindo K, Akagi A, Ozaki T, Nakano H, Shimizu A, Komatsu J, Shima K, Ikeda T, Samuraki-Yokohama M, Hamaguchi T, Iwasa K, Tanaka K, Yamada M. Recovery from multidisciplinary therapy-refractory anti-NMDA receptor encephalitis after over three years of mechanical ventilation. Clin Neurol Neurosurg (In Press)

12. Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI, MGTX study group. Minimal manifestation status and prednisone withdrawal in the MGTX trial. Neurology 95:e755-766, 2020

13. Mannina C, Tugcu A, Jin Z, Russo C, Matsumoto K, Ito K, Homma S, Elkind MSV, Rundek T, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR. Left atrial strain and subclinical cerebrovascular disease in older adults. JACC Cardiovasc Imaging (In Press)

14. Matsubayashi T, Akaza M, Hayashi Y, Hamaguchi T, Yamada M, Shimohata T, Yokota T, Sanjo N. Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease. Prion 14:207-213, 2020

15. Matsumoto K, Jin Z, Homma S, Elkind MSV, Rundek T, Mannina C, Lee TC, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR. Association between central blood pressure and subclinical cerebrovascular disease in older adults. Hypertension 75:580-587, 2020

16. Miwa T, Sakai K, Nakano H, Yamada M. Sarcoid neuropathy with conduction block showing nerve fascicle compression by perineurial granuloma formation. Clin Neurol Neurosurg 196:105962, 2020

17. Nakamura-Shindo K, Ono K, Koh K, Ishiura H, Tsuji S, Takiyama Y, Yamada M. A novel mutation in the GBA2 gene in a Japanese patient with SPG46: A case report. eNeurologicalSci 19:100238, 2020

18. Nakamura-Shindo K, Sakai K, Shimizu A, Ishida C, Yamada M. Accumulation of phosphorylated TDP-43 in the cytoplasm of Schwann cells in a case of sporadic amyotrophic lateral sclerosis. Neuropathology 40:606-610, 2020

19. Nakanishi M, Igarashi A, Ueda K, Brnabic AJM, Treuer T, Sato M, Kahle-Wrobleski K, Meguro K, Yamada M, Mimura M, Arai H. Costs and resource use associated with community-dwelling patients with Alzheimer’s disease in Japan: baseline results from the prospective observational GERAS-J study. J Alzheimers Dis 74:127-138, 2020

20. Ninomiya T, Nakaji S, Maeda T, Yamada M, Mimura M, Nakashima K, Mori T, Takebayashi M, Ohara T, Hata J, Kokubo Y, Uchida K, Taki Y, Kumagai S, Yonemoto K, Yoshida H, Muto K, Momozawa Y, Akiyama M, Kubo M, Ikeda M, Kanba S, Kiyohara Y. Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD). Environ Health Prev Med 25:64, 2020

21. Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M. Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression. Sci Rep 10:18627, 2020

22. Noguchi-Shinohara M, Domoto C, Yoshida T, Niwa K, Yuki-Nozaki S, Samuraki-Yokohama M, Sakai K, Hamaguchi T, Ono K, Iwasa K, Matsunari I, Komai K, Nakamura H, Yamada M. A new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment and dementia around 5 min. PLoS One 15:e0243469, 2020 *equally contributed

23. Odake Y, Koh K, Takiyama Y, Ishiura H, Tsuji S, Yamada M, Yoshita M. Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia. Neurol Genet 6:e514, 2020

24. Oji Y, Hatano T, Ueno S-I, Funayama M, Ishikawa K, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu Y-R, Matsuda J, Hattori N. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain 143:1190-1205, 2020

25. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Harada M, Mizusawa H, Yamada M. Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease. J Neurol Sci 418:117094, 2020

26. Sakai K, Noguchi-Shinohara M, Ikeda T, Hamaguchi T, Ono K, Yamada M. Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammation. Acta Neurol Scand (In Press)

27. Shima A, Hamaguchi T, Tada Y, Yamada M. Treatment with rituximab in acute phase of relapsing remitting multiple sclerosis: A case report. Intern Med 59:121-124, 2020

28. Tada Y, Hamaguchi T, Ikeda Y, Iwasa K, Nishida Y, Nakamura M, Sano A, Yamada M. Chorea-acanthocytosis with a novel mutation in the vacuolar protein sorting 13 homolog a gene: a case report. J Neurol Sci 412:116731, 2020

29. Usui Y, Nakano H, Komatsu J, Nakamichi K, Saijo M, Takano S, Kamiya K-I, Hamaguchi T, Yamada M. Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma. Leuk Lymphoma 61:2234-2237, 2020

30. Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P, Attems J, Ayalon G, Beach TG, Bigio EH, Budson A, Cairns NJ, Corrada M, Cortes E, Dickson DW, Fischer P, Flanagan ME, Franklin E, Gearing M, Glass J, Hansen LA, Haroutunian V, Hof PR, Honig L, Kawas C, Keene CD, Kofler J, Kovacs GG, Lee EB, Lutz MI, Mao Q, Masliah E, McKee AC, McMillan CT, Mesulam MM, Murray M, Nelson PT, Perrin R, Pham T, Poon W, Purohit DP, Rissman RA, Sakai K, Sano M, Schneider JA, Stein TD, Teich AF, Trojanowski JQ, Troncoso JC, Vonsattel J-P, Weintraub S, Wolk DA, Woltjer RL, Yamada M, Yu L, White CL, Crary JF. Early selective vulnerability of the CA2 hippocampal subfield in primary age-related tauopathy. J Neuropathol Exp Neurol (In Press)

31. Wißfeld J, Nozaki I, Mathews M, Raschka T, Ebeling C, Hornung V, Brüstle O, Neumann H. Deletion of Alzheimer’s disease-associated CD33 results in an inflammatory human microglia phenotype. Glia (In Press) *equally contributed

32. Yamamoto S, Kayama T, Noguchi-Shinohara M, Hamaguchi T, Yamada M, Abe K, Kobayashi S. Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. npj Science of Food (In Press)

33. Yoshida S, Tada H, Nishikawa T, Nakagawa-Kamiya T, Nakahashi T, Sakai K, Sakata K, Kawashiri MA, Yamada M, Takamura M. Antegrade balloon aortic valvuloplasty for the highly frail patient of severe aortic stenosis complicated with transthyretin-type cardiac amyloidosis. Intern Med 59:1053-1057, 2020

Reviews

1. Takamori M. Myasthenia gravis: from the viewpoint of pathogenicity focusing on acetylcholine receptor clustering, trans-synaptic homeostasis and synaptic stability. Front Mol Neurosci 13:86, 2020

2. Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M. Diagnostic criteria for dementia with Lewy bodies: Updates and future directions. J Mov Disord 13:1-10, 2020

Presentations (International meeting)

Invited lectures

1. Yamada M. 地域コホートを起点とする認知症予防法開発。第3回認知症国際アジア会議 in 加賀、加賀、January 17-18, 2020

2. Yamada M. Transmission of Aβ pathology leading to early-onset cerebral amyloid angiopathy in humans. 2nd AAT-AD/PD Focus Meeting 2020, Wien (WEB), April 2-5, 2020

Presentations

1. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Kawashima A. The cause of death in pathologically confirmed amyotrophic lateral sclerosis with mechanical ventilation assist, a retrospective hospital-based study. 72nd Annual meeting of AAN (American Academy of Neurology), Toronto(WEB), April 25-May 1, 2020

2. Wißfeld J, Nozaki I, Mathews M, Brüstle O, Neumann H. CD33 signaling. PHAGO 5th General Assembly Meeting, Basel(WEB), November 2-4, 2020